Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Carlos Andrés Gallardo-Garrido"'
Autor:
Hery Chung, Rodrigo Osorio, Martin Hodar-Salazar, Ramiro Araya-Maturana, Julio Rodríguez-Lavado, Claudio Saitz, Michael Mallea, Marcos Lorca, Patricio Iturriaga-Vásquez, Jaime Mella-Raipán, Pablo Jaque, C. David Pessoa-Mahana, Carlos Andrés Gallardo-Garrido, Victor Bustos, Miguel Reyes-Parada, Hernán Pessoa-Mahana
Publikováno v:
European journal of medicinal chemistry. 198
During the last decade, the one drug-one target strategy has resulted to be inefficient in facing diseases with complex ethiology like Alzheimer’s disease and many others. In this context, the multitarget paradigm has emerged as a promising strateg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ef006c8e2af3dd89f05fdc1e4d869f61
https://pubmed.ncbi.nlm.nih.gov/32388114
https://pubmed.ncbi.nlm.nih.gov/32388114
Autor:
Hernán Pessoa-Mahana, Ramiro Araya-Maturana, Claudio Saitz-Barría, Eduardo Gallardo-Toledo, C. David Pessoa-Mahana, Claudio Méndez-Rojas, Maria C. Zuniga-Lopez, Carla Valenzuela-Gutiérrez, Gabriel Quiroz, Carlos Andrés Gallardo-Garrido, Patricio Iturriaga-Vásquez, Hery Chung, Marcelo J. Kogan, Mario Faúndez
Publikováno v:
Archiv Der Pharmazie
Artículos CONICYT
CONICYT Chile
instacron:CONICYT
Artículos CONICYT
CONICYT Chile
instacron:CONICYT
With the purpose of expanding the structural variety of chemical compounds available as pharmacological tools for the treatment of Alzheimer's disease, we synthesized and evaluated a novel series of indole-benzoxazinones (Family I) and benzoxazine-ar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ee5a56711ed847f062d29ed8afb6311
https://doi.org/10.1002/ardp.201800024
https://doi.org/10.1002/ardp.201800024